Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction

Journal of Urology

Volumn 189, Issue 1, 2013, Pages 238-242

  Prabhu, Vinay ^a   Alukal, Joseph P ^a   Laze, Juliana ^a   Makarov, Danil V ^a,b,c,d   Lepor, Herbert ^a,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

erectile dysfunction; injections; postoperative complications; prostate; prostatectomy

Indexed keywords

SILDENAFIL; TADALAFIL;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BODY MASS; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT SATISFACTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL RETROPUBIC PROSTATECTOMY; SCORING SYSTEM; SEXUAL FUNCTION;

ERECTILE DYSFUNCTION; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTATECTOMY; TIME FACTORS;

EID: 84870873901     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.089     Document Type: Article

References (29)

1. S. Shikanov, S.E. Eggener Hazard of prostate cancer specific mortality after radical prostatectomy J Urol 187 2012 124
2. M. Alemozaffar, M.M. Regan, M.R. Cooperberg Prediction of erectile function following treatment for prostate cancer JAMA 306 2011 1205
3. Y. Arai, K. Okubo, Y. Aoki Patient-reported quality of life after radical prostatectomy for prostate cancer Int J Urol 6 1999 78
4. M.S. Litwin, S.C. Flanders, D.J. Pasta Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE Cancer of the Prostate Strategic Urologic Research Endeavor Urology 54 1999 503
5. M.G. Sanda, R.L. Dunn, J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
6. R. Segal, A.L. Burnett Erectile preservation following radical prostatectomy Ther Adv Urol 3 2011 35
7. B. Fallon Intracavernous injection therapy for male erectile dysfunction Urol Clin North Am 22 1995 833
8. J.P. Mulhall, A.E. Jahoda, M. Cairney The causes of patient dropout from penile self-injection therapy for impotence J Urol 162 1999 1291
9. A. Claro Jde, J.E. de Aboim, M. Maringolo Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study Sao Paulo Med J 119 2001 135
10. R. Raina, M.M. Lakin, M. Thukral Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis Int J Impot Res 15 2003 318
11. L. Rodriguez Vela, A. Gonzalvo Ibarra, A. Bono Arino Erectile dysfunction after radical prostatectomy Etiopathology and treatment Actas Urol Esp 21 1997 909
12. C.P. Sundaram, W. Thomas, L.E. Pryor Long-term follow-up of patients receiving injection therapy for erectile dysfunction Urology 49 1997 932
13. S.E. Althof, L.A. Turner, S.B. Levine Why do so many people drop out from auto-injection therapy for impotence? J Sex Marital Ther 15 1989 121
14. A. Casabe, A. Bechara, G. Cheliz Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction Int J Impot Res 10 1998 5
15. J.N. Weiss, G.H. Badlani, R. Ravalli Reasons for high drop-out rate with self-injection therapy for impotence Int J Impot Res 6 1994 171
16. A. de laTaille, V. Delmas, E. Amar Reasons of dropout from short- and long-term self-injection therapy for impotence Eur Urol 35 1999 312
17. K. Purvis, I. Egdetveit, E. Christiansen Intracavernosal therapy for erectile failure-impact of treatment and reasons for drop-out and dissatisfaction Int J Impot Res 11 1999 287
18. R.J. Flynn, G. Williams Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine Br J Urol 78 1996 628
19. M.B. Irwin, E.J. Kata High attrition rate with intracavernous injection of prostaglandin E1 for impotency Urology 43 1994 84
20. L. Lundberg, J.O. Olsson, B. Kihl Long-term experience of self-injection therapy with prostaglandin E1 for erectile dysfunction Scand J Urol Nephrol 30 1996 395
21. H. Porst, J. Buvat, E. Meuleman Intracavernous Alprostadil Alfadex-an effective and well tolerated treatment for erectile dysfunction Results of a long-term European study Int J Impot Res 10 1998 225
22. T. Domes, E. Chung, L. DeYoung Clinical outcomes of intracavernosal injection in postprostatectomy patients: a single-center experience Urology 79 2012 150
23. L. Glickman, G. Godoy, H. Lepor Changes in continence and erectile function between 2 and 4 years after radical prostatectomy J Urol 181 2009 731
24. S.K. Hong, S.H. Doo, D.S. Kim The 5-year functional outcomes after radical prostatectomy: a real-life experience in Korea Asian J Androl 12 2010 835
25. W. Hsiao, N. Bennett, P. Guhring Satisfaction profiles in men using intracavernosal injection therapy J Sex Med 8 2011 512
26. R. Virag, K. Shoukry, J. Floresco Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases J Urol 145 1991 287
27. O.I. Linet, F.G. Ogrinc Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction The Alprostadil Study Group N Engl J Med 334 1996 873
28. F. van derWindt, G.R. Dohle, J. van derTak Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction BJU Int 89 2002 901
29. M. Godschalk, D. Gheorghiu, P.G. Katz Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1 J Urol 156 1996 999